Skip to Main Content

Author Details

Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
1997
191
44
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36250584Validity of the American College of Radiology Thyroid Imaging Reporting and Data System in Children.Laryngoscope2023
37546993Polyamine transport inhibition and cisplatin synergistically enhance tumor control through oxidative stress in murine head and neck cancer models.bioRxiv2023
37425842Lysosomal mitochondrial interaction promotes tumor growth in squamous cell carcinoma of the head and neck.bioRxiv2023
37387167Deriving spatial features from in situ proteomics imaging to enhance cancer survival analysis.Bioinformatics2023
36896866Discharge Disposition After Head and Neck Reconstruction: Effect on Adjuvant Therapy and Outcomes.Laryngoscope2023
36595540Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.Clin Cancer Res2023
34272656Surgeon satisfaction and outcomes of tele-proctoring for robotic gynecologic surgery.J Robot Surg2022
35734044Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis.Laryngoscope Investig Otolaryngol2022
35625959Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.Cancers (Basel)2022
36474663A phase â¿¡ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.World J Otorhinolaryngol Head Neck Surg2022
36357512Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens.Nat Biomed Eng2022
36052496Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36052495Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
35944904Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study.J Natl Cancer Inst2022
33751213Assessing the learning curve associated with a novel flexible robot in the pre-clinical and clinical setting.Surg Endosc2022
35286200Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.Proc Natl Acad Sci U S A2022
34915753Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.Thyroid2022
35245888A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.Oral Oncol2022
35091445Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.Clin Cancer Res2022
35020252Poor treatment tolerance in head and neck cancer patients with low muscle mass.Head Neck2022
34762303Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.Cancer2022
34699271Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).J Clin Oncol2022
34687456Chronic Lymphocytic Thyroiditis and Aggressiveness of Pediatric Differentiated Thyroid Cancer.Laryngoscope2022
32239774TORS Base-of-Tongue Mucosectomy in Human Papilloma Virus-Negative Carcinoma of Unknown Primary.Laryngoscope2021
33842364Safety and Feasibility of Surgery for Oropharyngeal Cancers During the SARS-CoV-2-Pandemic.Front Oncol2021
33888713Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.Nat Commun2021
34921143Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.Nat Commun2021
34878821Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.Sci Transl Med2021
34546978Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.JCI Insight2021
34715452Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity.Oral Oncol2021
34132440Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.Head Neck2021
34099645B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma.Nat Commun2021
34261774Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.Clin Cancer Res2021
33428218PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.Laryngoscope2021
32974970Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.Head Neck2021
32282087Quality and Readability Assessment of Websites on Human Papillomavirus and Oropharyngeal Cancer.Laryngoscope2021
31183606Reconstruction of TORS oropharyngectomy defects with the nasoseptal flap via transpalatal tunnel.J Robot Surg2020
31924475Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.Immunity2020
31648864Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.Oral Oncol2020
33039096Robotics in Otolaryngology.Otolaryngol Clin North Am2020
32943205Robotic Neck Dissection.Otolaryngol Clin North Am2020
32679405A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.Oral Oncol2020
32338790Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach.Head Neck2020
32117738Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer.Front Oncol2020
32415114Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.Sci Rep2020
32383520Society of Robotic Surgery review: recommendations regarding the risk of COVID-19 transmission during minimally invasive surgery.BJU Int2020
32329958Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.Head Neck2020
32545260Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer.Cancers (Basel)2020
32467187Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.AJNR Am J Neuroradiol2020
32324430Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline.J Clin Oncol2020
  • 1 - 50 of 191

Recommended Authors

Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 5
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 6
Beverly Hills Center for Facial Plastic Surgery
Career Start Year 2012
Number of shared co-authors 9
University of Washington
Career Start Year 2011
Number of shared co-authors 3
Schulich School of Medicine & Dentistry, Western University
Career Start Year 2010
Number of shared co-authors 8
university of california san diego
Career Start Year 2010
Number of shared co-authors 9
University of Washington
Career Start Year 2009
Number of shared co-authors 9
Western University
Career Start Year 2009
Number of shared co-authors 5
Gold Coast University Hospital
Career Start Year 2008
Number of shared co-authors 5
University of California at Davis School of Medicine
Career Start Year 2008
Number of shared co-authors 5
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 14
Niigata Prefectural Tokamachi Hospital.
Career Start Year 2007
Number of shared co-authors 6
University of Tokyo
Career Start Year 2005
Number of shared co-authors 13
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 7
University of California San Diego Moores Cancer Center La Jolla California USA.
Career Start Year 2005
Number of shared co-authors 10
University of British Columbia
Career Start Year 2004
Number of shared co-authors 7
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 10
Tokai University
Career Start Year 2002
Number of shared co-authors 13
Montreal Hospital
Career Start Year 2002
Number of shared co-authors 3
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Stanford University
Career Start Year 1999
Number of shared co-authors 8
Queen's University
Career Start Year 1998
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 10
Princess Margaret Cancer Centre
Career Start Year 1992
Number of shared co-authors 12
Cumming School of Medicine, University of Calgary
Career Start Year 1990
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 10
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 7
Princess Margaret Cancer Centre
Career Start Year 1984
Number of shared co-authors 12
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 12

Collaborators

University of California san francisco
Co-authored papers 23
University of Pittsburgh
Co-authored papers 19
George Washington University
Co-authored papers 18
University of Pittsburgh Medical Center-Presbyterian
Co-authored papers 16
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 8
University of California san francisco
Co-authored papers 8
University of California San Francisco
Co-authored papers 8
University of Pittsburgh Medical Center, Eye and Ear Institute
Co-authored papers 8
Zai Lab (US) LLC
Co-authored papers 7
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 7
Parker Institute for Cancer Immunotherapy
Co-authored papers 7
University of Wisconsin School of Medicine and Public Health
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 5
University Hospital Wurzburg
Co-authored papers 5
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
University of California San Francisco
Co-authored papers 5
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
The University of New Mexico School of Medicine
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
2Mayo Clinic
Co-authored papers 3
J. David Gladstone Institutes
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Co-authored papers 3
Center for Coregulator Research, Baylor College of Medicine
Co-authored papers 3
University of North Carolina at Chapel Hill
Co-authored papers 2
Co-authored papers 2